For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
NZMA applauds Professor Emeritus Sir Mason Harold Durie becoming a member of the Order of New Zealand
This item is over 2 years old; some content may no longer be current
+Undoctored
NZMA applauds Professor Emeritus Sir Mason Harold Durie becoming a member of the Order of New Zealand
Thursday 31 December 2020, 06:30 PM

The New Zealand Medical Association applauds the announcement of Professor Emeritus Sir Mason Harold Durie as a member of the Order of New Zealand in the New Year’s Honours List.
For the past four decades and more Sir Mason Durie has ‘walked the talk’, transforming Māori Health through the development of the Māori heath workforce and leading by example where it matters,” says Dr Kate Baddock, Chair of the New Zealand Medical Association. “His work is more relevant than ever as we continue to strive to improve Māori Health and equity in Aotearoa.”